Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Enlyte
Article
Macro Signals: Workers’ Compensation and Personal Auto
Enlyte
Article
Macro Signals: State of the P&C Industry
Workers' Comp
Article
Complex Claims Need More Than a UR Determination
For claims teams, a utilization review (UR) decision can answer an important clinical question.
Register Now
Virtual Event
Why Bodily Injury Claims are Being Overpaid and How to Stop It
Fixing the Breakdown in Demand Evaluation
Workers' Comp
Article
The Next Generation of Claim Handlers Is Forcing a Rethink of How Referral Management Gets Done
The claims industry is not only adopting new technology. It is also being reshaped by a new workforce.
Claims Journal
Article